Navigation Links
Varian, Inc. Reports Fourth Quarter 2009 Results
Date:11/4/2009

=========== =========== NON-GAAP (ADJUSTED) FINANCIAL MEASURES (see also attached reconciliations of GAAP to Adjusted results for each of these measures): (1) $441,730 on an adjusted basis excluding $6,117 in acquisition- related intangible amortization, $131 in acquisition-related inventory write-up amortization and $4,076 in restructuring and other related costs. (2) $224,255 on an adjusted basis excluding $9,155 in costs related to the pending acquisition by Agilent, $1,118 in acquisition-related intangible amortization and $4,754 in restructuring and other related costs. (3) $55,583 on an adjusted basis excluding $842 in restructuring and other related costs. (4) $85,176 on an adjusted basis excluding the adjustments described in items (1) - (3) above. (5) $27,294 on an adjusted basis excluding the tax impact of the adjustments described in items (1) - (3) above. (6) $58,046 and $2.01 per share, respectively, on an adjusted basis excluding the adjustments (net of related tax effects) described in items (1) - (3) above. (7) $550,465 on an adjusted basis excluding $6,547 in acquisition-related intangible amortization, $1,408 in acquisition-related inventory write-up amortization and $1,641 in restructuring and other related costs. (8) $273,072 on an adjusted basis excluding $1,825 in acquisition-related intangible amortization and $2,581 in restructuring and other related costs. (9) $70,556 on an adjusted basis excluding $1,254 in restructuring and other related costs. (10) $0 on an adjusted basis excluding $1,703 related to an acquisition- related in-process research and development charge. (11) $118,422 on an adjusted basis excluding the adjustments described in items (7) - (10) above. (12) $0 on an adjusted basis exc
'/>"/>
SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Varian, Inc. to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results
2. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
3. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
4. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
5. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
6. Cambrex Reports Third Quarter 2009 Results
7. Regeneron Reports Third Quarter 2009 Financial and Operating Results
8. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
9. Uroplasty Reports Results for Second Quarter FY2010
10. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
11. Mettler-Toledo International Inc. Reports Third Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... ASHBURN, Va., Sept. 26 Innocoll, Inc., a ... updates regarding its clinical development programs and specialty,pharmaceutical ... Applications already approved in 2007., ... US phase 3 multi-centered clinical ...
... Flu and The, Clorox Company Team Up to Vaccinate Thousands of ... ... A new report by the,Centers for Disease Control and Prevention (CDC) shows ... vaccination actually get,one, despite the CDC recommendations that all children six months ...
Cached Medicine Technology:Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 2Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 3Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 4Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 5Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 6Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Don't Vaccinate 2Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Don't Vaccinate 3Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Don't Vaccinate 4Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Don't Vaccinate 5
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... January 22, 2015 Yesterday, Senator ... (D-Concord) and Kristin Olsen (R-Modesto) were honored by ... in advancing biotechnology, biomedical science, medical device and ... each received the “2014 Life Sciences Champion” award ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
(Date:1/22/2015)... Step into a macabre world where plants hold ... Wicked Plants, the Museum’s latest featured exhibition, opens Saturday, ... and diabolical plants inside of a dilapidated, Victorian home. ... physical and neurological processes between botanicals and the human ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... The University of Rhode Island's Cancer Prevention Research Center ... them from substance abuse . The outcome is based ... change smoking and other high-risk behaviors of teenagers and ... 5-year grant from the National Institute of Drug Abuse ...
... a schoolteacher in Chandigarh, is a woman on a mission ... efforts despite facing raised-eyebrows of many offended parents. ... or homosexuality, have often left several parents complaining about her ... ,Behl says she is doing a social ...
... Commonwealth Fund have found that the United States, which has ... among other major rich countries for quality, access and ... consistently inferior in performance, to other countries and differs most ... insurance coverage, according to the studies. ,Says ...
... the efficacy of the DOTS program to control the ... of TB cases recorded throughout the country indicates ... has been implemented, according to the Indian Medical Association. ... programs that are used for a few years before ...
... Thai Health Minister Mongkol Na Songkhla on Tuesday said ... reduced-cost versions of patented drugs if pharmaceutical companies ... makers, Reuters AlertNet reports. Mongkol's comments came one day ... agreement on the price of Abbott's antiretroviral drugs Aluvia ...
... degree of trust and confidence in doctors reflects the reality ... the immense efforts from doctors to improve the quality ... pressures placed upon the health service. ,In virtually ... the majority of respondents have answered that doctors are providing ...
Cached Medicine News:Health News:New Substance Use Prevention Program Being Developed 2Health News:New Substance Use Prevention Program Being Developed 3Health News:New Substance Use Prevention Program Being Developed 4Health News:A School Teachers Crusade to Promote Sex Education 2Health News:Americans Get Least Value For Money In Healthcare 2Health News:Thailand Will Not Issue Compulsory Licenses for Patented Drugs 2
... Oxygen flowmeter with a Lexan®inner calibrated flow ... and manufacturing defects. A wide range of ... Also available with all popular inlet connections, ... double unit configurations. Our extra large knob ...
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
... the entire series of time-tested Timeter® Classic ... needs of care providers and patients alike. ... You can see it in the craftsmanship. ... year after year. Every Timeter® Classic Flowmeter ...
... entire series of time-tested Timeter® Classic Flowmeters ... of care providers and patients alike. You ... can see it in the craftsmanship. You ... after year. Every Timeter® Classic Flowmeter is ...
Medicine Products: